Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Cash from Financing Activities: 2020-2025

Historic Cash from Financing Activities for Roivant Sciences (ROIV) over the last 4 years, with Sep 2025 value amounting to $62.6 million.

  • Roivant Sciences' Cash from Financing Activities rose 157.38% to $62.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 billion, marking a year-over-year decrease of 1062.61%. This contributed to the annual value of -$1.2 billion for FY2025, which is 390.87% down from last year.
  • Per Roivant Sciences' latest filing, its Cash from Financing Activities stood at $62.6 million for Q3 2025, which was up 133.33% from -$187.8 million recorded in Q2 2025.
  • Over the past 5 years, Roivant Sciences' Cash from Financing Activities peaked at $452.0 million during Q4 2023, and registered a low of -$1.0 billion during Q4 2024.
  • Over the past 3 years, Roivant Sciences' median Cash from Financing Activities value was -$50.8 million (recorded in 2023), while the average stood at -$158.8 million.
  • In the last 5 years, Roivant Sciences' Cash from Financing Activities skyrocketed by 2,931.66% in 2023 and then slumped by 8,935.31% in 2024.
  • Quarterly analysis of 5 years shows Roivant Sciences' Cash from Financing Activities stood at $305.7 million in 2021, then dropped by 5.43% to $289.1 million in 2022, then soared by 56.33% to $452.0 million in 2023, then slumped by 330.68% to -$1.0 billion in 2024, then skyrocketed by 157.38% to $62.6 million in 2025.
  • Its last three reported values are $62.6 million in Q3 2025, -$187.8 million for Q2 2025, and -$1.0 billion during Q4 2024.